Aquestive therapeutics reports fourth quarter and full year 2024 financial results and provides business update

Warren, n.j., march 05, 2025 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (“aquestive” or the “company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today reported financial results for the fourth quarter and full year ended december 31, 2024, and provided a progress update on the key 2025 objectives previously outlined by the company.
AQST Ratings Summary
AQST Quant Ranking